Our research results show that targeting HIF-2α regulation may serve as a new approach to alleviate hypoxic stress, interfere with the YAP signalling pathways, and prevent fibrosis progression in NAFLD. This evidence concerns the gene YAP1 and metabolic dysfunction-associated steatotic liver disease.